Filtered By:
Countries: France Health

This page shows you your search results in order of date. This is page number 9.

Order by Relevance | Date

Total 2568 results found since Jan 2013.

COVID-19 Vaccination as a Trigger of IgA Vasculitis: Truth or Illusion?
J Rheumatol. 2023 Mar 15:jrheum.221189. doi: 10.3899/jrheum.221189. Online ahead of print.ABSTRACTWe read with great interest the recent article by Ramdani and colleagues in The Journal of Rheumatology on a nationwide multicenter, retrospective study conducted in France describing the status of the occurrence of IgA vasculitis (IgAV) after coronavirus disease 2019 (COVID-19) vaccination.1 We support and appreciate the authors' work and agree with their conclusions that IgA vasculitis following COVID-19 vaccination is usually benign and that a fortuitous link cannot be ruled out and now requires a worldwide pharmacovigilanc...
Source: J Rheumatol - March 15, 2023 Category: Rheumatology Authors: Gang Wang Ying Luo Bihui Li Jie Li Source Type: research

French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19)
We described ADR profile with casirivimab/imdevimab reported as suspect/interacting drug to the French pharmacovigilance network and the pharmaceutical company between 17/03/2021 and 30/06/2022. Data presented correspond to the 2 periods of the pharmacovigilance survey: the first carried out by the pharmaceutical company for curative and prophylactic uses and the second by Toulouse university regional pharmacovigilance center (RPVC).RESULTS: A total of 384 reports were analysed and 256 were "serious". ADR profile was comparable between the 2 periods and between curative and prophylactic use, corresponding to expected ADRs ...
Source: Therapie - March 14, 2023 Category: Psychiatry & Psychology Authors: Claire de Canecaude Fran çois Montastruc Sandrine Bergeron Paola Sanchez-Pena Aur élie Grandvuillemin French Network of Regional Pharmacovigilance Centers Source Type: research

An ancient coronavirus from individuals in France, circa 16th century
: At the time when the COVID-19 pandemic was responsible for more than six million deaths worldwide, the antiquity of Coronaviruses remains undefined. We investigated individuals buried in 16th century in France, for the direct and paleoserological diagnosis of Coronavirus.
Source: International Journal of Infectious Diseases - March 14, 2023 Category: Infectious Diseases Authors: Hamadou Oumarou Hama, Thomas Chenal, Olivier Pible, Guylaine Miotello, Jean Armengaud, Michel Drancourt Source Type: research

Roll-out and effectiveness of HIV pre-exposure prophylaxis in France: An overview
CONCLUSION: PrEP roll-out has been strongly impacted by the COVID-19 pandemic in France. Although it has been substantial among men who have sex with men, additional measures are needed to expand access to PrEP to all other population groups that could benefit from it. Promoting adherence to PrEP (especially among young people and the socioeconomically disadvantaged) will be essential to ensure a higher level of PrEP effectiveness, which has been shown to be lower in real-life settings than in clinical trials.PMID:36894453 | DOI:10.1016/j.therap.2023.02.010
Source: Therapie - March 9, 2023 Category: Psychiatry & Psychology Authors: Sophie Billioti de Gage Hugo Jourdain David Desplas Rosemary Dray-Spira Source Type: research

Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: a win-win bet with Health Authorities!
Therapie. 2023 Feb 22:S0040-5957(23)00046-X. doi: 10.1016/j.therap.2023.02.009. Online ahead of print.ABSTRACTThe pandemic subsequent to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus resulted, for the French institutional pharmacovigilance, in a "health crisis" in 2 phases: the coronavirus disease 2019 - "COVID-19" phase during which the missions of the Regional Pharmacovigilance Centres (RPVC) were to detect a possible impact of drugs on this disease, as whether existed a possible aggravating role of certain drugs, or the safety profile of drugs used for the management of COVID-19 could evolve. Th...
Source: Therapie - March 8, 2023 Category: Psychiatry & Psychology Authors: Annie Pierre Jonville-Bera Sophie Gautier Jo ëlle Micallef Nathalie Massy Marina Atzenhoffer Milou-Daniel Drici Aur élie Grandvuillemin R éseau français des centres régionaux de pharmacovigilance Source Type: research

Excess mortality among non-COVID-19 surgical patients attributable to the exposure of French intensive and intermediate care units to the pandemic
ConclusionSignificant excess mortality essentially occurred outside of the ICU/IMCU, suggesting that access of surgical patients to critical care was limited.
Source: Intensive Care Medicine - February 25, 2023 Category: Intensive Care Source Type: research

Risk, time preferences, trustworthiness and COVID-19 preventive behavior: evidence from France
AbstractWe analyze how far-sightedness and risk aversion as well as the perceived trustworthiness of others correlate with COVID-19-related protective behaviors in France. We leverage individual-level data from the corona survey of the Survey of Health Aging and Retirement in Europe linked with a paper questionnaire survey about preferences conducted in France just before the coronavirus outbreak. Our results suggest that far-sightedness and risk aversion are strong predictors of individuals ’ protective behavior. More far-sighted individuals are more likely to not visit their family members anymore, wear a mask, and kee...
Source: The European Journal of Health Economics - February 19, 2023 Category: Health Management Source Type: research

Covid-19 as an Independent Risk Factor for Weight Loss in Older Adults living in Nursing Homes
Conclusion For nursing home residents, COVID-19 was an independent risk factor for weight loss. Weight loss was most common in residents needing close mealtime supervision, suggesting that organizational issues may have affected the quality of the nutritional care provided during the lockdown.
Source: Gerontology - February 17, 2023 Category: Geriatrics Source Type: research